Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.6%

3 terminated out of 65 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

42%

27 trials in Phase 3/4

Results Transparency

17%

7 of 41 completed with results

Key Signals

7 with results93% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (16)
P 1 (2)
P 2 (5)
P 3 (8)
P 4 (19)

Trial Status

Completed41
Unknown12
Recruiting4
Not Yet Recruiting3
Terminated3
Active Not Recruiting1

Trial Success Rate

93.2%

Benchmark: 86.5%

Based on 41 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT07558707Not Yet RecruitingPrimary

Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice

NCT07458490Not Yet Recruiting

Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound

NCT07315711Not Yet Recruiting

The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients

NCT07260006Not ApplicableRecruiting

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

NCT07139366Phase 4Recruiting

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

NCT07123259Not ApplicableCompleted

Ulcer Pomegranate Muffins

NCT05742568Phase 4Completed

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

NCT06284876Phase 3RecruitingPrimary

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

NCT04702542Not ApplicableActive Not Recruiting

To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

NCT00450658Phase 3CompletedPrimary

Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers

NCT06439563Phase 3RecruitingPrimary

Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers

NCT04784910Phase 3CompletedPrimary

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

NCT04678492Phase 4Completed

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

NCT05237115Phase 4Completed

Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy

NCT04025983Not ApplicableTerminated

Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection

NCT03868267Unknown

Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting

NCT04636866CompletedPrimary

The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019

NCT03814421Not ApplicableUnknown

Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding

NCT04140591Phase 2Terminated

Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis

NCT00766961Not ApplicableTerminatedPrimary

TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy

Scroll to load more

Research Network

Activity Timeline